Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Beclot 500mg/250mg Tablet MR

Prescription Icon
Prescription Required

Marketer

Bipi Lifesciences Pvt Ltd

Salt Composition

Tranexamic Acid (500mg) + Mefenamic Acid (250mg)

Overview Beclot 500mg/250mg Tablet MR

Tranexamic acid/mefenamic acid 500mg/250mg modified-release tablets are a combined medication indicated for managing heavy menstrual bleeding and associated pain. This treatment stabilizes blood clots, thus reducing excessive menstrual flow. It also inhibits the production of pain and inflammation-inducing chemical mediators. The tablets can be taken with food at any time of day, but consistent daily timing is recommended. For optimal efficacy, initiation should coincide with the first day of menstruation. Continue treatment as directed by your physician. Take the prescribed dose and duration; if a dose is missed, take it as soon as remembered. Complete the full course of treatment, even with symptom improvement. Report to your doctor if menstrual bleeding patterns don't improve after three consecutive cycles. Common side effects include nausea, abdominal pain, headache, nasal congestion, sinusitis, skin rash, fatigue, and musculoskeletal discomfort. Diarrhea is also possible; increased fluid intake is advisable to mitigate dehydration. Consult your physician if menstrual flow remains unchanged after three consecutive cycles. Prior to commencing treatment, disclose any kidney issues, vaginal bleeding disorders, or current pregnancies/breastfeeding to your doctor. Inform your physician about all other medications being taken. Regular eye examinations may be required during treatment. Alcohol consumption should be avoided while using this medication.

Uses of Beclot 500mg/250mg Tablet MR

Managing excessive menstrual flow and menstrual discomfort.

Major Benefits of Beclot 500mg/250mg Tablet MR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Beclot 500mg/250mg Modified-Release Tablet should be taken with a meal.

Common Side effects of Beclot 500mg/250mg Tablet MR:

  • Nausea
  • Vomiting
  • Heartburn
  • Indigestion
  • Diarrhea
  • Loss of appetite
  • Nasal congestion (stuffy nose)
  • Headache
  • Tiredness
  • Musculoskeletal (bone, muscle or joint) pain
  • Anemia (low number of red blood cells)
  • Stomach pain
  • Sinus pain
  • Sinus inflammation

How to use Beclot 500mg/250mg Tablet MR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg/250mg Beclot MR tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with food.

How Beclot 500mg/250mg Tablet MR works:

Beclot 500mg/250mg MR tablets contain Tranexamic Acid and Mefenamic Acid, working synergistically to manage heavy menstrual bleeding. Tranexamic Acid, an antifibrinolytic agent, stabilizes blood clots, thus reducing excessive bleeding. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits prostaglandin synthesis, alleviating associated pain and inflammation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Beclot 500mg/250mg MR tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Beclot 500mg/250mg MR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The extended-release Beclot 500mg/250mg tablet is likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.

DrivingDrivingUNSAFE

Taking Beclot 500mg/250mg MR tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Beclot 500mg/250mg MR tablets cautiously, as dosage modification may be necessary. Consult a physician before use. Beclot 500mg/250mg MR tablets are contraindicated in those with severe kidney disease.

LiverLiverSAFE IF PRESCRIBED

The use of Beclot 500mg/250mg MR tablets in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.

What if you forget to take Beclot 500mg/250mg Tablet MR :

Should you forget a Beclot 500mg/250mg MR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Beclot 500mg/250mg Tablet MR

LabelValue
Potential for Dependence None.
Type of Medication Hematological

FAQs on Beclot 500mg/250mg Tablet MR

Each Beclot 500mg/250mg modified-release tablet contains Tranexamic Acid and Mefenamic Acid, working together to manage pain and heavy menstrual bleeding in women.
Indeed, its use is contraindicated in individuals experiencing severe renal impairment, active intravascular thrombosis, and color vision deficiencies.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Beclot 500mg/250mg Tablet...
140
MRP 170
17% off